Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FEMY is expected to report earnings to fall 24.81% to -100 cents per share on November 17
Q3'26
Est.
$-1.00
Q2'26
Missed
by $0.20
Q1'26
Beat
by $1.80
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.03
The last earnings report on August 17 showed earnings per share of -133 cents, missing the estimate of -112 cents. With 30.64K shares outstanding, the current market capitalization sits at 24.08M.